• In March 2026, Novanta Inc. announced it had joined the NVIDIA Halos AI Systems Inspection Lab, an ANAB-accredited facility focused on validating AI-driven physical systems, to align its motion control and sensing technologies with NVIDIA safety platforms such as NVIDIA IGX Thor.
• This collaboration aims to make it easier for robotics and physical AI equipment makers to certify warehouse automation, industrial robotics, and emerging humanoid platforms by ensuring Novanta’s hardware and subsystems are interoperable with NVIDIA’s full-stack safety architecture.
• Next, we will examine how participation in NVIDIA’s Halos AI Systems Inspection Lab could influence Novanta’s investment narrative around robotics expansion.

We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Novanta Investment Narrative Recap

To own Novanta, you need to believe its motion control and sensing technologies can become core building blocks in higher value robotics and industrial automation, despite currently modest organic growth and earnings pressure. Joining NVIDIA’s Halos AI Systems Inspection Lab looks incrementally positive for that story, but does not change the near term catalyst of improving organic demand or the key risk that emerging robotics applications might not scale fast enough to justify today’s valuation.

Recent guidance for 2026, with expected GAAP revenue of US$1,030 million to US$1,050 million, frames how investors weigh this NVIDIA collaboration: it adds credibility to Novanta’s robotics ambitions, but execution still depends on converting design wins into sustained orders. Against recent earnings volatility and a sharp share price pullback, investors may see this certification work as one potential offset, rather than a fix, for concerns about end market recovery.

Yet investors should also be aware that if warehouse automation and humanoid robotics adoption stalls, Novanta’s exposure to these nascent markets could...

Novanta’s narrative projects $1.2 billion revenue and $148.8 million earnings by 2029. This requires 6.5% yearly revenue growth and about a $95 million earnings increase from $53.8 million today.

Uncover how Novanta's forecasts yield a $160.00 fair value, a 41% upside to its current price.

Exploring Other Perspectives

Three fair value estimates from the Simply Wall St Community span roughly US$112 to US$160 per share, showing how far apart individual views can be. Against that backdrop, the dependence on still emerging robotics and warehouse automation markets invites you to weigh how different growth assumptions could affect Novanta’s longer term earnings power.

Explore 3 other fair value estimates on Novanta - why the stock might be worth as much as 41% more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Novanta research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision.
• Our free Novanta research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Novanta's overall financial health at a glance.

Ready For A Different Approach?

Our top stock finds are flying under the radar-for now. Get in early:

• Rare earth metals are the new gold rush. Find out which 26 stocks are leading the charge.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 22 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.